Recombinant Monoclonal Anti-HER2 Antibody, Rabbit (5D5), Ready-To-Use

用户评价
货号-规格
价格
Qty.
CAA-B004-7.5ml
¥10015.00
合计0件 产品金额¥ 0

产品详情

  • 产品概述(Product Overview)

    The HER2 receptor is a transmembrane glycoprotein with tyrosine kinase activity. It belongs to the epidermal growth factor receptor family (EGFR/ErbB). These receptors are essential in controlling epithelial cell growth and differentiation. The HER2 IHC Antibody (5D5) is a ready-to-use antibody working solution to detect HER2 across tumors to identify patients eligible for multiple targeted therapies. Kit product are manufactured in a dedicated GMP facility and are compliant with our ISO 13485 quality management system.

  • 产品参数(Product Specifications)

    Analyte
    HER2
    Format
    7.5ml
    Reactivity
    Human
    Species
    Rabbit
    Regulatory Status
    RUO
    Applicable Platform
    LEICA BOND III
  • 组分(Materials Provided)

    Recombinant Monoclonal Anti-HER2 Antibody, Rabbit (5D5)

  • 应用说明(Application)

    The kit is developed for use in the HER2 protein in the formalin-fixed, paraffin-embedded tissue. It is indicated as an aid in the assessment of HER2 expression in human tissues.

  • 状态(State)

    Liquid

  • 存储(Storage)

    Stored at 2°C to 8°C. The shelf life is 30 days from the date of opening.

  • 质量管理控制体系(QMS)

    1. 质量管理体系(ISO, GMP)
    2. 质量优势
    3. 质控流程

推荐产品

数据展示

  • 质控样本(Control Sample)

     Her2 CONTROL SAMPLE

    Use ACRO HER2 5D5 kit to stain human tonsil tissue, positive cell membrane specific positive staining (staining intensity ≥ 1), no non-specific staining (staining intensity < 1) , no background staining (staining intensity < 1 ).

肿瘤样本(Cancer Sample)
  • 扩展性(Extensibility)

    ACRO HER2 5D5 expandable test: gastric cancer and breast Cancer.

     Her2 EXTENSIBILITY
     Her2 EXTENSIBILITY

    Use HER2 5D5 kit to stain gastric cancer and breast cancer tissue samples respectively.

用户评价
发表评论

前沿进展

 
药物研发进展
  • 英文全称:

    Receptor protein-tyrosine kinase erbB-2

  • 中文全称:

    受体蛋白酪氨酸激酶 erbB-2

  • 种类:

  • 上市药物数量:

    39 详情

  • 临床药物数量:

    201 详情

  • 最高研发阶段:

    批准上市

联系我们
项目合作
查看更多项目
实验案例分析
查看更多案例分析
  • 产品基础信息
  • 产品详情
  • 推荐产品
  • 数据展示
  • 用户评价